Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
90,438,636
-
Total 13F shares
-
42,643,720
-
Share change
-
-4,449,397
-
Total reported value
-
$5,195,793,257
-
Put/Call ratio
-
119%
-
Price per share
-
$121.85
-
Number of holders
-
431
-
Value change
-
-$576,803,869
-
Number of buys
-
269
-
Number of sells
-
159
Institutional Holders of CRISPR Therapeutics AG - Common Stock (CRSP) as of Q1 2021
As of 31 Mar 2021 CRISPR Therapeutics AG - Common Stock (CRSP) had 431 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 42,643,720 shares of stock of the company.
Largest 10 holders included ARK Investment Management LLC, Capital International Investors, Nikko Asset Management Americas, Inc., NEA Management Company, LLC, Versant Venture Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., TWO SIGMA INVESTMENTS, LP, WADDELL & REED FINANCIAL INC, and TWO SIGMA ADVISERS, LP.
This table shows 431 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.